Multiparameter immunoprofiling differentiates progressive from nonprogressive nontuberculous mycobacteria lung disease (NTM-LD)
P. Marty (Rochester, United States), B. Pathakumari (Rochester, United States), V. Van Keulen (Rochester, United States), M. Shah (Rochester, United States), T. Peikert (Rochester, United States), P. Escalante (Rochester, United States)
Source: International Congress 2022 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and NTM
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Marty (Rochester, United States), B. Pathakumari (Rochester, United States), V. Van Keulen (Rochester, United States), M. Shah (Rochester, United States), T. Peikert (Rochester, United States), P. Escalante (Rochester, United States). Multiparameter immunoprofiling differentiates progressive from nonprogressive nontuberculous mycobacteria lung disease (NTM-LD). 4099
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|